Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza

BACKGROUND: Danirixin (DNX), a selective and reversible CXC chemokine receptor 2 antagonist, inhibits neutrophil transmigration and activation. This study assessed the safety, tolerability, and clinical effect of DNX with and without oseltamivir (OSV) in adults with acute, uncomplicated influenza. M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Roberts, Grace, Chen, Shuguang, Yates, Phillip, Madan, Anuradha, Walker, Jill, Washburn, Michael L, Peat, Andrew J, Soucie, Gary, Kerwin, Edward, Roy-Ghanta, Sumita
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Major Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6476494/
https://ncbi.nlm.nih.gov/pubmed/31024969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz072
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars